Risk factors associated with the deterioration of renal function after kidney transplantation

Kidney International

Volumn 68, Issue SUPPL. 99, 2005, Pages

  Serón, Daniel ^a   Fulladosa, Xavier ^a   Moreso, Francesc ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Renal function; Renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; CALCINEURIN; CREATININE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADAPTATION; CHRONIC ALLOGRAFT NEPHROPATHY; CONFERENCE PAPER; CORRELATION ANALYSIS; GLOMERULUS FILTRATION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; AGING; BLOOD; DONOR; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULUS; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; REVIEW; TIME; VASCULARIZATION; VASOCONSTRICTION;

AGING; CALCINEURIN; CREATININE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TACROLIMUS; TIME FACTORS; TISSUE DONORS; VASOCONSTRICTION;

EID: 33748288081     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.09921.x     Document Type: Conference Paper

References (33)

1. HARIHARN S, MCBRIDE MA, CHERIKH WS, et al: Post-transplant renal function in the first year predicts long term-renal kidney transplant survival. Kidney Int 62:311-318, 2002
2. SERÓN D, ARIAS M, CAMPISTOL JM, MORALES JM FOR THE SPANISH CHRONIC ALLOGRAFT NEPHROPATHY STUDY GROUP: Late renal allograft failure between 1990 and 1998 in Spain: a changing scenario. Transplantation 76:1588-1594, 2003
3. MARIAT C, ALAMARTINE E, BATHELEMY JC, et al: Assessing renal graft function in clinical trials: Can tests predicting glomerular filtration rate substitute for a referred method? Kidney Int 65:289-297, 2004
4. SERÓN D, GÓMEZ-ULLATE P, GUTIERREZ-COLÓN JA, et al: Early posttransplant renal allograft function between 1990 and 1998 in Spain. Nephrol Dial Transplant 19(Suppl 3):S43-S46, 2004
5. GOURISHANKAR S, HUNSICKER LG, JHANGRI GS, et al: The stability of the glomerular filtration rate after renal transplantation is improving. J Am Soc Nephro 14:2387-2394, 2003
6. SIDDIQI N, MCBRIDE MA, HARIHARAN S: Similar risk profiles for post-transplant renal dysfunction and long term graft failure: UNOS/OPTN database analysis. Kidney Int 65:1906-1913, 2004
7. HARIHARAN S, MC BRIDE M, COHEN EP: Evolution of endpoints for renal transplant outcome. Am J Transplant 3:933-941, 2003
8. KEITH DS, DEMATTOS A, GOLCONDA M, et al: Factors associated with improvement in deceased donor renal allograft function in the 1990s. J Am Soc Nephrol 16:1512-1521, 2005
9. MEIER-KRIESCHE HU, SCHOLD JD, KAPLAN B: Long term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies. Am J Transplant 4:1289-1295, 2004
10. GILL JS, TONELLI M, MIX CH, et al: The effect of maintenance immunosuppression medication on the change in kidney allograft function. Kidney Int 65:692-699, 2004
11. EUROPEAN MYCOPHENOLATE MOFETIL COOPERATIVE STUDY GROUP: Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325, 1995
12. MARGREITER R FOR THE EUROPEAN TACROLIMUS VS. CYCLOSPORIN MICROEMULSION RENAL TRANSPLANTATION STUDY GROUP: Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal transplantation: A randomised multicentre study. Lancet 359:741-746, 2002
13. NANKIVELL BJ, BORROWS RJ, FUNG CL, et al: The natural history of chronic allograft nephropathy. N Engl J Med 349:2326-2333, 2003
14. MORESO F, SERÓN D, CARRERA M, et al: Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation 78:1064-1068, 2004
15. OJO AO, MEIER-KRIESCHE HU, HANSON J, et al: Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69:2405-2409, 2000
16. GONZALEZ-MOLINA M, SERÓN D, GARCIA DEL MORL R, et al: Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. Transplantation 77:215-220, 2004
17. KREIS H, OBERBAUER R, CAMPISTOL JM, et al: Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 15:809-817, 2004
18. FLECHNER SM, KURIAN SM, SOLEZ K, et al: De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 4:1776-1785, 2004
19. SERÓN D, MORESO F, BOVER J, et al: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51:310-316, 1997
20. SERÓN D, MORESO F, RAMÓN JM, et al: Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 69:1849-1855, 2000
21. FULLADOSA X, MORESO F, TORRAS J, et al: Structural and functional correlations in stable renal allografts. Am J Kidney Dis 41:1065-1073, 2003
22. MORESO F, LOPEZ M, VALLEJOS A, et al: Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable grafts. Am J Transplant 1:82-88, 2001
23. NYENGAARD JR, BENDTSEN TF: Glomerular number and size in relation to age, kidney weight and body surface area in normal man. Anat Rec 232:194-201, 1992
24. HOY WE, DOUGLAS-DENTON RN, HUGHSON MD, et al: A stereological study of glomerular number and volume: Preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int 63(Suppl 83):S31-S37, 2003
25. BARKER DJ, OSMOND C, GOLDING J, et al: Growth in utero, blood pressure in childhood and adult life and mortality from cardiovascular disease. Br Med J 298:564-567, 1989
26. KELLER G, ZIMMER G, MALL G, et al: Nephron number in patients with primary hypertension. N Engl J Med 348:101-108, 2003
27. BRENNER BM, MILFORD L: Nephron underdosing: A programmed cause of chronic renal allograft failure. Am J Kidney Dis 21:66-72, 1993
28. ABDI R, SLAKEY D, KITTUR D, et al: Baseline glomerular size as a predictor of function in human renal transplantation. Transplantation 66:329-333, 1998
29. TERASAKI PI, GJERTSON DW, CECKA JM, TAKEMOTO S: Fit and match hypothesis for kidney transplantation. Transplantation 62:441-445, 1996
30. CRUZADO JM, TORRAS J, RIERA M, et al: Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischaemia. Am J Physiol Renal Physiol 279:F259-F269, 2000
31. BASGEN JM, STEFFES MW, STILLMAN AE, MAUER SM: Estimating glomerular number in situ using magnetic resonance imaging and biopsy. Kidney Int 45:1668-1672, 1994
32. ALPEROVICH G, MALDONADO R, MORESO F, et al: Glomerular enlargement assessed by paired donor and early protocol renal allograft biopsies. Am J Transplant 4:650-654, 2004
33. BATHENA DB: Glomerular size and the association of focal glomerulosclerosis in long-surviving human renal allografts. J Am Soc Nephrol 4:1316-1326, 1993